Alignment Healthcare (NASDAQ:ALHC) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Alignment Healthcare (NASDAQ:ALHC) announced its quarterly earnings data on Thursday. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02, Zacks reports. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%.

Alignment Healthcare Stock Up 2.4 %

Shares of Alignment Healthcare stock traded up $0.31 on Thursday, hitting $13.47. The company had a trading volume of 1,238,019 shares, compared to its average volume of 1,867,618. Alignment Healthcare has a twelve month low of $4.46 and a twelve month high of $15.82. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The stock has a 50-day moving average of $13.34 and a 200-day moving average of $11.88. The firm has a market capitalization of $2.58 billion, a P/E ratio of -17.49 and a beta of 1.50.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Hyong Kim sold 62,574 shares of the business’s stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $12.20, for a total value of $763,402.80. Following the completion of the transaction, the insider now owns 470,496 shares of the company’s stock, valued at $5,740,051.20. The trade was a 11.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Andreas P. Wagner sold 14,878 shares of the business’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total value of $213,945.64. Following the transaction, the insider now directly owns 200,885 shares of the company’s stock, valued at $2,888,726.30. This trade represents a 6.90 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 441,002 shares of company stock worth $5,772,726. Insiders own 6.60% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Stephens reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday. Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Barclays raised their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 30th. Finally, UBS Group raised their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.